Genetic variation in the lymphotoxin-α (LTA)/tumour necrosis factor-α (TNFα) locus as a risk factor for idiopathic achalasia

Gut

Volumn 63, Issue 9, 2014, Pages 1401-1409

  Wouters, Mira M ^a   Lambrechts, Diether ^b,c   Becker, Jessica ^d   Cleynen, Isabelle ^a   Tack, Jan ^a   Vigo, Ana G ^e   De León, Antonio Ruiz ^e   Urcelay, Elena ^e   De La Serna, Julio Pérez ^e   Rohof, Wout ^f   Annese, Vito ^g,h   Latiano, Anna ^g   Palmieri, Orazio ^g   Mattheisen, Manuel ^d,i   Mueller, Michaela ^j   Lang, Hauke ^k   Fumagalli, Uberto ^l   Laghi, Luigi ^l   Zaninotto, Giovanni ^m   Cuomo, Rosario ⁿ   Sarnelli, Giovanni ⁿ   Nöthen, Markus M ^d   Vermeire, Séverine ^a   Knapp, Michael ^d   Gockel, Ines ^k   Schumacher, Johannes ^d   Boeckxstaens, Guy E ^a   more..

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF BONN   (Germany)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^h Azienda Ospedaliera Universitaria   (Italy)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^j DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^k UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^l HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^m UNIVERSITY OF PADOVA   (Italy)

ⁿ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; INTERLEUKIN 13; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC RECEPTOR BETA 2 GENE; ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ESOPHAGUS ACHALASIA; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IDIOPATHIC ACHALASIA; IDIOPATHIC DISEASE; INTERLEUKIN 13 GENE; ITALY; LYMPHOTOXIN ALPHA GENE; MAJOR CLINICAL STUDY; MALE; MYOSIN 5B GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; TUMOR NECROSIS FACTOR ALPHA GENE;

ACHALASIA; GENETIC POLYMORPHISMS;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; ESOPHAGEAL ACHALASIA; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HUMANS; LOGISTIC MODELS; LYMPHOTOXIN-ALPHA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905495434     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-304848     Document Type: Article

References (66)

1. Hirano I, Tatum RP, Shi G, et al. Manometric heterogeneity in patients with idiopathic achalasia. Gastroenterology 2001;120:789-98. (Pubitemid 32193174)
2. Mearin F, Mourelle M, Guarner F, et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest 1993;23:724-8. (Pubitemid 23349139)
3. Clark SB, Rice TW, Tubbs RR, et al. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol 2000;24:1153-8. (Pubitemid 30612838)
4. Villanacci V, Annese V, Cuttitta A, et al. An immunohistochemical study of the myenteric plexus in idiopathic achalasia. J Clin Gastroenterol 2010;44:407-10.
5. Facco M, Brun P, Baesso I, et al. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol 2008;103:1598-609.
6. Storch WB, Eckardt VF, Junginger T. Complement components and terminal complement complex in ooesophageal smooth muscle of patients with achalasia. Cell Mol Biol (Noisy-le-grand) 2002;48:247-52.
7. Kraichely RE, Farrugia G, Pittock SJ, et al. Neural autoantibody profile of primary achalasia. Dig Dis Sci 2010;55:307-11.
8. Moses PL, Ellis LM, Anees MR, et al. Antineuronal antibodies in idiopathic achalasia and gastro-ooesophageal reflux disease. Gut 2003;52:629-36. (Pubitemid 36528861)
9. Latiano A, De GR, Volta U, et al. HLA and enteric antineuronal antibodies in patients with achalasia. Neurogastroenterol Motil 2006;18:520-5. (Pubitemid 43855805)
10. Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C, et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci 2002;47:15-19. (Pubitemid 34075010)
11. Annese V, Napolitano G, Minervini MM, et al. Family occurrence of achalasia. J Clin Gastroenterol 1995;20:329-30.
12. Gordillo-Gonzalez G, Guatibonza YP, Zarante I, et al. Achalasia familiar: report of a family with an autosomal dominant pattern of inherence. Dis Oesophagus 2011;24:E1-4.
13. de la Concha EG, Fernandez-Arquero M, Mendoza JL, et al. Contribution of HLA class II genes to susceptibility in achalasia. Tissue Antigens 1998;52:381-4. (Pubitemid 28467013)
14. de la Concha EG, Fernandez-Arquero M, Conejero L, et al. Presence of a protective allele for achalasia on the central region of the major histocompatibility complex. Tissue Antigens 2000;56:149-53. (Pubitemid 30621281)
15. Verne GN, Hahn AB, Pineau BC, et al. Association of HLA-DR and-DQ alleles with idiopathic achalasia. Gastroenterology 1999;117:26-31. (Pubitemid 29297616)
16. Santiago JL, Martinez A, Benito MS, et al. Gender-specific association of the PTPN22 C1858T polymorphism with achalasia. Hum Immunol 2007;68:867-70. (Pubitemid 47599718)
17. Nunez C, Garcia-Gonzalez MA, Santiago JL, et al. Association of IL10 promoter polymorphisms with idiopathic achalasia. Hum Immunol 2011;72:749-52.
18. de Leon AR, de la Serna JP, Santiago JL, et al. Association between idiopathic achalasia and IL23R gene. Neurogastroenterol Motil 2010;22:734-8, e218.
19. Paladini F, Cocco E, Cascino I, et al. Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene. Neurogastroenterol Motil 2009;21:597-602.
20. Alahdab YO, Eren F, Giral A, et al. Preliminary evidence of an association between the functional c-kit rs6554199 polymorphism and achalasia in a Turkish population. Neurogastroenterol Motil 2012;24:27-30.
21. Mearin F, Garcia-Gonzalez MA, Strunk M, et al. Association between achalasia and nitric oxide synthase gene polymorphisms. Am J Gastroenterol 2006;101:1979-84. (Pubitemid 44337619)
22. Vigo AG, Martinez A, de la Concha EG, et al. Suggested association of NOS2A polymorphism in idiopathic achalasia: no evidence in a large case-control study. Am J Gastroenterol 2009;104:1326-7.
23. Perrin RJ, Fagan AM, Holtzman DM. Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 2009;461:916-22.
24. Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature 2006;441:1094-6. (Pubitemid 43990722)
25. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008;455:894-902.
26. Ludwig KU, Mangold E, Herms S, et al. Genome-wide meta-analyses of nonsyndromic cleft lip with or without cleft palate identify six new risk loci. Nat Genet 2012;44:968-71.
27. Mangold E, Ludwig KU, Birnbaum S, et al. Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate. Nat Genet 2010;42:24-6.
28. Hillmer AM, Brockschmidt FF, Hanneken S, et al. Susceptibility variants for male-pattern baldness on chromosome 20p11. Nat Genet 2008;40:1279-81.
29. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009;5:e1000529.
30. Durbin RM, Altshuler DL, Durbin RM, et al. A map of human genome variation from population-scale sequencing. Nature 2010;467:1061-73.
31. Lambrechts D, Claes B, Delmar P, et al. VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials. Lancet Oncol 2012;13:724-33.
32. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-50. (Pubitemid 36150192)
33. Boeckxstaens GE. Achalasia: virus-induced euthanasia of neurons? Am J Gastroenterol 2008;103:1610-12.
34. Ware CF. Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 2005;23:787-819. (Pubitemid 40563185)
35. Kumaraguru U, Davis IA, Deshpande S, et al. Lymphotoxin alpha-/-mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system. J Immunol 2001;166:1066-74. (Pubitemid 32060264)
36. Steinberg MW, Cheung TC, Ware CF. The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation. Immunol Rev 2011;244:169-87.
37. Ware CF, Sedy JR. TNF Superfamily Networks: bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14). Curr Opin Immunol 2011;23:627-31.
38. Rutgeerts P, Van AG, Vermeire S. Optimizing anti-TNF treatment in inflammatory bowel disease. Gastroenterology 2004;126:1593-610. (Pubitemid 38649876)
39. Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001;19:163-96. (Pubitemid 32368033)
40. Schett G, Coates LC, Ash ZR, et al. Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future. Arthritis Res Ther 2011;13(Suppl 1):S4.
41. Ferguson LR, Huebner C, Petermann I, et al. Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World J Gastroenterol 2008;14:4652-61.
42. Sanchez R, Levy E, Costea F, et al. IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location. World J Gastroenterol 2009;15:3776-82.
43. Puthothu B, Bierbaum S, Kopp MV, et al. Association of TNF-alpha with severe respiratory syncytial virus infection and bronchial asthma. Pediatr Allergy Immunol 2009;20:157-63.
44. Genuneit J, Cantelmo JL, Weinmayr G, et al. A multi-centre study of candidate genes for wheeze and allergy: the International Study of Asthma and Allergies in Childhood Phase 2. Clin Exp Allergy 2009;39:1875-88.
45. Hildebrandt MA, Komaki R, Liao Z, et al. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS ONE 2010;5:e12402.
46. Clancy RM, Marion MC, Kaufman KM, et al. Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus. Arthritis Rheum 2010;62:3415-24.
47. Laws SM, Perneczky R, Wagenpfeil S, et al. TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels. Hum Mutat 2005;26:29-35. (Pubitemid 40980700)
48. Fletcher GJ, Samuel P, Christdas J, et al. Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population. Genes Immun 2011;12:552-8.
49. Limou S, Le CS, Coulonges C, et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 2009;199:419-26.
50. O'Rielly DD, Roslin NM, Beyene J, et al. TNF-alpha-308 G/A polymorphism and responsiveness to TNF-alpha blockade therapy in moderate to severe rheumatoid arthritis: a systematic review and meta-analysis. Pharmacogenomics J 2009;9:161-7.
51. Lee YH, Harley JB, Nath SK. Meta-analysis of TNF-alpha promoter-308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet 2006;14:364-71.
52. Gaudet MM, Egan KM, Lissowska J, et al. Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet 2007;121:483-90. (Pubitemid 46554685)
53. Canova C, Hashibe M, Simonato L, et al. Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project. Cancer Res 2009;69:2956-65.
54. Diakite M, Clark TG, Auburn S, et al. A genetic association study in the Gambia using tagging polymorphisms in the major histocompatibility complex class III region implicates a HLA-B associated transcript 2 polymorphism in severe malaria susceptibility. Hum Genet 2009;125:105-9.
55. Singal DP, Li J, Zhu Y. HLA class III region and susceptibility to rheumatoid arthritis. Clin Exp Rheumatol 2000;18:485-91. (Pubitemid 30623436)
56. Markus T, Hansson SR, Cronberg T, et al. beta-Adrenoceptor activation depresses brain inflammation and is neuroprotective in lipopolysaccharide- induced sensitization to oxygen-glucose deprivation in organotypic hippocampal slices. J Neuroinflammation 2010;7:94.
57. Rodriguez OC, Cheney RE. Human myosin-Vc is a novel class V myosin expressed in epithelial cells. J Cell Sci 2002;115(Pt 5):991-1004. (Pubitemid 34257384)
58. Muller T, Hess MW, Schiefermeier N, et al. MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity. Nat Genet 2008;40:1163-5.
59. Beghe B, Hall IP, Parker SG, et al. Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease. Allergy 2010;65:474-81.
60. Cameron L, Webster RB, Strempel JM, et al. Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation. J Immunol 2006;177:8633-42. (Pubitemid 44893827)
61. Kiesler P, Shakya A, Tantin D, et al. An allergy-associated polymorphism in a novel regulatory element enhances IL13 expression. Hum Mol Genet 2009;18:4513-20.
62. Maier LM, Howson JM, Walker N, et al. Association of IL13 with total IgE: evidence against an inverse association of atopy and diabetes. J Allergy Clin Immunol 2006;117:1306-13. (Pubitemid 43795740)
63. Burton PR, Clayton DG, Cardon LR, et al. Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007;39:1329-37. (Pubitemid 350041542)
64. Tatton W, Chen D, Chalmers-Redman R, et al. Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer's disease: anti-apoptosis by alpha-2-adrenergic receptor activation. Surv Ophthalmol 2003;48(Suppl 1):S25-37. (Pubitemid 41126693)
65. Kalapesi FB, Coroneo MT, Hill MA. Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection. Br J Ophthalmol 2005;89:758-63. (Pubitemid 40780587)
66. McWhinney-Glass S, Winham SJ, Hertz DL, et al. Cumulative genetic risk predicts platinum/taxane-induced neurotoxicity. Clin Cancer Res 2013;19:5769-76.